Terms: = Lymphoma AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Diagnosis
38 results:
1. Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019.
van der Straten L; Levin MD; Dinnessen MAW; Visser O; Posthuma EFM; Doorduijn JK; Langerak AW; Kater AP; Dinmohamed AG
Blood Cancer J; 2023 Jan; 13(1):15. PubMed ID: 36635262
[TBL] [Abstract] [Full Text] [Related]
2. Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution.
Richter-Pechańska P; Kunz JB; Rausch T; Erarslan-Uysal B; Bornhauser B; Frismantas V; Assenov Y; Zimmermann M; Happich M; von Knebel-Doeberitz C; von Neuhoff N; Köhler R; Stanulla M; Schrappe M; Cario G; Escherich G; Kirschner-Schwabe R; Eckert C; Avigad S; Pfister SM; Muckenthaler MU; Bourquin JP; Korbel JO; Kulozik AE
Leukemia; 2022 Jul; 36(7):1759-1768. PubMed ID: 35585141
[TBL] [Abstract] [Full Text] [Related]
3. IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice.
Sancho JM; Marín-Niebla A; Fernández S; Capote FJ; Cañigral C; Grande C; Donato E; Zeberio I; Puerta JM; Rivas A; Pérez-Ceballos E; Vale A; Martín García-Sancho A; Salar A; González-Barca E; Teruel A; Pastoriza C; Conde-Royo D; Sánchez-García J; Barrenetxea C; Arranz R; Hernández-Rivas JÁ; Ramírez MJ; Jiménez A; Rubio-Azpeitia E
Int J Hematol; 2022 Sep; 116(3):381-392. PubMed ID: 35551632
[TBL] [Abstract] [Full Text] [Related]
4. [Clinicopathological features of mature T/NK cell lymphoma with aberrant CD20 or CD79α expression].
Li DJ; Kang H; Zhang L; Xu ZG; Wang XY; Wang LF; Song XX; Kong LF
Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):413-418. PubMed ID: 35511636
[No Abstract] [Full Text] [Related]
5. [Sjogren's disease/syndrome in combination with autoimmune liver damage. 20-years observation].
Gaiduk IV; Vasiliev VI; Fakhrislamova LR; Panin AM; Palshina SG; Rodionova EB
Stomatologiia (Mosk); 2021; 100(6):108-114. PubMed ID: 34953198
[TBL] [Abstract] [Full Text] [Related]
6. Outcomes of HTLV-1 Carriers with Diffuse Large B-Cell lymphoma: A Single-Center Retrospective Matched Cohort Study.
Valcarcel B; Ampuero GS; de la Cruz-Ku G; Enriquez DJ; Malpica L
Clin Lymphoma Myeloma Leuk; 2022 Apr; 22(4):251-259. PubMed ID: 34690089
[TBL] [Abstract] [Full Text] [Related]
7. What is the optimal time to initiate hypomethylating agents (HMAs) in higher risk myelodysplastic syndromes (MDSs)?
Komrokji R; Al Ali N; Padron E; Lancet J; Nazha A; Steensma D; DeZern A; Roboz G; Garcia-Manero G; Sekeres MA; Sallman D
Leuk Lymphoma; 2021 Nov; 62(11):2762-2767. PubMed ID: 34114922
[TBL] [Abstract] [Full Text] [Related]
8. [Clinical characteristics and prognosis of Waldenström's macroglobulinemia: a clinical data report from a single center].
Jia YC; Lu J; Qiang WT; Li L; Liu J; Jiang H; Fu WJ; Du J
Zhonghua Xue Ye Xue Za Zhi; 2020 Dec; 41(12):1020-1024. PubMed ID: 33445850
[No Abstract] [Full Text] [Related]
9. [Clinical characteristics and prognostic analysis of pediatric pro-B cell acute lymphoblastic leukemia].
Xue YJ; Lu AD; Wang Y; Jia YP; Zuo YX; Zhang LP
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Dec; 22(12):1286-1294. PubMed ID: 33327999
[TBL] [Abstract] [Full Text] [Related]
10. Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers.
Evens AM; Danilov A; Jagadeesh D; Sperling A; Kim SH; Vaca R; Wei C; Rector D; Sundaram S; Reddy N; Lin Y; Farooq U; D'Angelo C; Bond DA; Berg S; Churnetski MC; Godara A; Khan N; Choi YK; Yazdy M; Rabinovich E; Varma G; Karmali R; Mian A; Savani M; Burkart M; Martin P; Ren A; Chauhan A; Diefenbach C; Straker-Edwards A; Klein AK; Blum KA; Boughan KM; Smith SE; Haverkos BM; Orellana-Noia VM; Kenkre VP; Zayac A; Ramdial J; Maliske SM; Epperla N; Venugopal P; Feldman TA; Smith SD; Stadnik A; David KA; Naik S; Lossos IS; Lunning MA; Caimi P; Kamdar M; Palmisiano N; Bachanova V; Portell CA; Phillips T; Olszewski AJ; Alderuccio JP
Blood; 2021 Jan; 137(3):374-386. PubMed ID: 32663292
[TBL] [Abstract] [Full Text] [Related]
11. [Application of nuclear magnetic dispersion weighted imaging and apparent diffusion coefficient in the identification of benign].
Li ZL; Nan J; Cui YT; Du XS; Hao HC; Zhang JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 33(4):342-346. PubMed ID: 30970406
[No Abstract] [Full Text] [Related]
12. Brentuximab Vedotin for Patients With Refractory lymphomatoid Papulosis: An Analysis of Phase 2 Results.
Lewis DJ; Talpur R; Huen AO; Tetzlaff MT; Duvic M
JAMA Dermatol; 2017 Dec; 153(12):1302-1306. PubMed ID: 28980004
[TBL] [Abstract] [Full Text] [Related]
13. Clinical Indications and Impact on Management: Fourth and Subsequent Posttherapy Follow-up
Taghipour M; Marcus C; Sheikhbahaei S; Mena E; Prasad S; Jha AK; Solnes L; Subramaniam RM
J Nucl Med; 2017 May; 58(5):737-743. PubMed ID: 27811123
[TBL] [Abstract] [Full Text] [Related]
14. Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia.
Braun M; Pastorczak A; Fendler W; Madzio J; Tomasik B; Taha J; Bielska M; Sedek L; Szczepanski T; Matysiak M; Derwich K; Lejman M; Kowalczyk J; Kazanowska B; Badowska W; Styczynski J; Irga-Jaworska N; Trelinska J; Zalewska-Szewczyk B; Pierlejewski F; Wlodarska I; Młynarski W;
Leuk Lymphoma; 2017 May; 58(5):1162-1171. PubMed ID: 27756164
[TBL] [Abstract] [Full Text] [Related]
15. Complementary roles of bone scintigraphy and MR imaging in the detection and long-term follow-up of primary non-Hodgkin's bone lymphoma in a child-case report.
Marina V; Milena R; Vesna P; Slađana P; Vera A
Skeletal Radiol; 2015 Jun; 44(6):863-8. PubMed ID: 25433719
[TBL] [Abstract] [Full Text] [Related]
16. Second primary cancers after cancer of unknown primary in Sweden and Germany: efficacy of the modern work-up.
Liu H; Hemminki K; Sundquist J; Holleczek B; Katalinic A; Emrich K; Brenner H;
Eur J Cancer Prev; 2013 May; 22(3):210-4. PubMed ID: 22960777
[TBL] [Abstract] [Full Text] [Related]
17. Growth in the use of PET for six cancer types after coverage by medicare: additive or replacement?
Hillner BE; Tosteson AN; Song Y; Tosteson TD; Onega T; Goodman DC; Siegel BA
J Am Coll Radiol; 2012 Jan; 9(1):33-41. PubMed ID: 22221634
[TBL] [Abstract] [Full Text] [Related]
18. Dosimetric comparison of involved-field three-dimensional conformal photon radiotherapy and breast-sparing proton therapy for the treatment of Hodgkin's lymphoma in female pediatric patients.
Andolino DL; Hoene T; Xiao L; Buchsbaum J; Chang AL
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e667-71. PubMed ID: 21459527
[TBL] [Abstract] [Full Text] [Related]
19. The impact of hepatitis viruses on chronic lymphoproliferative disorders--preliminary results.
Vladareanu AM; Ciufu C; Neagu AM; Onisai M; Bumbea H; Vintilescu AM; Dobrea C; Arama V; Mihailescu R; Arama S
J Med Life; 2010; 3(3):320-9. PubMed ID: 20945824
[TBL] [Abstract] [Full Text] [Related]
20. Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission.
Nishiwaki S; Inamoto Y; Sakamaki H; Kurokawa M; Iida H; Ogawa H; Fukuda T; Ozawa Y; Kobayashi N; Kasai M; Mori T; Iwato K; Yoshida T; Onizuka M; Kawa K; Morishima Y; Suzuki R; Atsuta Y; Miyamura K
Blood; 2010 Nov; 116(20):4368-75. PubMed ID: 20664060
[TBL] [Abstract] [Full Text] [Related]
[Next]
